l The incineration by-products comply with the proposed Incineration Residue Pollution Control Limits (refer to Section 5.4.2 of this EIA Report); and
l The proposed mitigation measures for incineration by-products management activities are properly adopted.
l Hazard Identification
l Exposure Assessment
l Dose-response Assessment
l Risk/hazard Characterization
l Uncertainty Interpretation
Table 4.1 Identified COCs and Associated Health Hazards
for HHRA |
||
Respirable fraction of particulates has effects on health including respiratory illness, reduced lung function, morbidity and mortality rates increase at higher levels |
||
Certain organic compounds can give rise to odour nuisance and some have health effects on human |
||
At high concentration can cause bronchoconstriction and chemical bronchitis and tracheitis |
||
Long term effects of NOx exposure occur primarily in the lung, but also include spleen, liver and blood toxicity |
||
Cadmium (Cd) |
Long term effect of Cd inhalation may include bronchitis, emphysema and anaemia |
|
Thallium (Tl) |
Exposure can lead to pulmonary edema, convulsions, psychosis, liver and kidney damage |
|
Exposure of Hg vapour may induce effects on nervous system, oral mucosa and kidneys |
||
Antimony (Sb) |
Inhalation of dust and fumes can cause nose and throat irritation, inflammation of respiratory tract, pneumonitis, ulceration and perforation of the nasal septum, headaches, dyspnea, vomiting and diarrhea |
|
Ulceration of nasal septum, peripheral neuropathy, respiratory irritation |
||
Lead (Pb) |
Long term Pb exposure appears to cause increase in blood pressure and hypertension in adults. Short term exposure to high Pb levels can cause tiredness, irritability, abdominal pain and anaemia |
|
Manganese (Mn) |
Inhalation of Mn may cause pneumonia and bronchitis as well as changes in blood flow / chemistry |
|
Sensitization dermatitis, allergic asthma, pneumonitis |
||
Cough, fine rales, wheezing, bronchitis, dyspnea and eczema. Inhalation of V may also cause pneumonitis and bronchopneumonitis |
||
Polychlorinated dibenzodioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) (expressed as TCDD equivalent) |
The effects of long term exposure to dioxins include chloracne, liver damage, reproductive toxicity and depression of the immune system |
Table 4.2 Identified Potential Human Receptors
ASR |
Description |
Land Use |
Near Filed / Far Field |
A1 |
Ngau Hom Sha |
Residential |
Near Field |
A2 |
West Ha Pak Nai |
Residential |
Near Field |
A3 |
West Ha Pak Nai |
Residential |
Near Field |
A4 |
West Ha Pak Nai |
Residential |
Near Field |
A5 |
East Ha Pak Nai |
Residential |
Near Field |
A6 |
Black Point Power Station (Office) |
Industrial |
Near Field |
A7 |
EPD WENT Landfill Site Office |
Industrial |
Near Field |
A8 |
Lung Kwu Sheung Tan |
Residential |
Near Field |
A9 |
Sheung Pak Nai |
Residential |
Near Field |
A10 |
|
Recreational |
Far Field |
A11 |
Pak Long |
Residential |
Far Field |
A12 |
Leung King Estate |
Residential |
Far Field |
A13 |
Tsing Shan Monastery |
GIC |
Far Field |
A14 |
|
Residential |
Far Field |
A15 |
|
Recreational |
Far Field |
A16 |
San Shek Wan |
Residential |
Far Field |
A17 |
Tuen Mun Area 38 |
Residential |
Far Field |
A18 |
|
Industrial |
Far Field |
A19 |
Site Office of Castle Peak Power Company Limited |
Commercial |
Far Field |
A20 |
Site Office of |
Commercial |
Far Field |
A21 |
Lung Kwu Tan |
Residential |
Far Field |
A22 |
|
Place of public worship |
Near Field |
A23 |
Site Office of Shiu Wing Steel Mill |
Commercial |
Far Field |
A24 |
|
Residential |
Far Field |
A25 |
On Ting Estate |
Residential |
Far Field |
A26 |
Yau Oi Estate |
Residential |
Far Field |
A27 |
|
Residential |
Far Field |
A28 |
S.K.H. St.
Simon’s |
Education Institution |
Far Field |
A29 |
|
Residential |
Far Field |
A30 |
|
Residential |
Far Field |
A31 |
|
Residential |
Far Field |
A32 |
|
Residential |
Far Field |
l Determination of COC concentrations at identified potential human receptors; and
l Characterization of potential human receptors.
Table 4.3 Human Receptor Characteristic Parameter Values
Characteristic Parameter |
Value Adopted |
Unit |
Exposure frequency |
350 |
day/yr |
Exposure durationa |
20 (design life)b |
yr |
Averaging time |
70 |
yr |
a) Exposure frequency for off-site workers will be determined based on number of working days
b) Design life of 20 years for the STF should be set as a condition since the health risk will be underestimated if STF continues to operate beyond the design life.
l Relationship between the carcinogenic COC exposure and response in human;
l Relationship between long term COC exposure and non-carcinogenic health effect in human; and
l Relationship between acute COC exposure and non-carcinogenic health effect in human.
l WHO recommended URFs;
l USEPA recommended URFs (from IRIS database); and
l California EPA recommended URFs (from OEHHA).
Table 4.4 Inhalation Cancer Slope Factor and Unit Risk Factor for Carcinogenic COCs
Carcinogenic COCs |
Unit Risk Factor (μg/m3)-1 |
||
OEHHA (2005) |
WHO (2000) |
IRIS |
|
Cd |
4.2 x 10-3 |
- |
1.8 x 10-3 |
As |
3.3 x 10-3 |
1.5 x 10-3 |
4.3 x 10-3 |
Pb |
1.2 x 10-5 |
- |
- |
Cr (VI) |
1.5 x 10-1 |
4 x 10-2 |
1.2 x 10-2 |
Ni |
2.6 x 10-4 |
3.8 x 10-4 |
2.4 x 10-4 |
Dioxins |
38 |
- |
- |
l WHO recommended air quality standard;
l USEPA recommended air quality standard (inhalation reference concentration from IRIS database); and
l California EPA recommended air quality standard (chronic reference exposure level from OEHHA).
COCs |
Air Quality Standard / Occupational Exposure Limit Value (μg/m3) |
Averaging Time |
Country / City |
Source (a) |
Value Adopted / Derived (μg/m3) |
Note |
Sb |
500 (MEL) |
8-hr Time Weighted Average (TWA) |
UK |
HSE (2002) |
1 (=500/500) |
b, c, d, e |
As |
0.03 |
Chronic Exposure |
California |
OEHHA (2005) |
0.03 |
b, c, d |
CO |
No guideline |
- |
- |
- |
- |
b, c, d, e |
Cd |
0.005* 0.02 |
Annual Chronic Exposure |
WHO standard California |
WHO (2000) OEHHA (2005) |
0.02 |
b, d |
Cr (VI) |
0.008 (chromic acid mists and dissolved Cr VI aerosols) 0.2 (as Cr VI) |
Chronic Exposure
Chronic Exposure |
IRIS inhalation reference concentration (RfC) California |
IRIS
OEHHA (2005) |
0.008 |
b, c |
Co |
100 (MEL) |
8-hr TWA |
UK |
HSE (2002) |
0.2 (=100/500) |
b, c, d, e |
Cu |
200 (OES) |
8-hr TWA |
UK |
HSE (2002) |
2 (=200/100) |
b, c, d, e |
Dioxins |
0.00004 |
Chronic Exposure |
California |
OEHHA (2005) |
0.00004 |
b, c, d |
HCl |
20 9 |
Chronic Exposure Chronic Exposure |
IRIS RfC California |
IRIS OEHHA (2005) |
20 |
b, c |
HF |
14 1,500 (OES) |
Chronic Exposure 8 -hr TWA |
California UK |
OEHHA (2005) HSE (2002) |
14 |
b, c, d |
Pb |
1.5 |
3-month |
Hong Kong |
HKAQO |
1.5 |
d, e |
Mn |
0.15 0.05 0.2 |
Annual Chronic Exposure Chronic Exposure |
WHO standard IRIS RfC California |
WHO (2000) IRIS OEHHA (2005) |
0.15 |
b |
Hg |
1 0.3 (elemental Hg) 0.09 |
Annual Chronic Exposure Chronic Exposure |
WHO standard IRIS RfC California |
WHO (2000) IRIS OEHHA (2005) |
1 |
b |
NOx, as NO2 |
80 |
Annual |
Hong Kong |
HKAQO |
80 |
d, e |
Ni |
0.05 (except NiO2) 0.1 (NiO2) |
Chronic Exposure |
California |
OEHHA (2005) |
0.05 |
b, c, d |
Particulates |
55 |
Annual |
Hong Kong |
HKAQO |
55 |
c, d, e |
SO2 |
80 |
Annual |
Hong Kong |
HKAQO |
80 |
d, e |
Tl |
100 (OES) |
8-hr TWA |
UK |
HSE (2002) |
1 (=100/100) |
b, c, d, e |
V |
50 (MEL) |
8-hr TWA |
UK |
HSE (2002) |
0.1 (=50/500) |
b, c, d, e |
Notes
* The guideline value by WHO is based on the prevention of further increase of cadmium in agricultural soils, which is considered not applicable to the risk assessment for the current study.
(a) Sources of References:
HKAQO: http://www.epd-asg.gov.hk/english/backgd/hkaqo.php
WHO (2000): http://www.euro.who.int/document/e71922.pdf
USEPA (IRIS): http://cfpub.epa.gov/ncea/iris/index.cfm
OEHHA(2005): http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html
HSE (2002): Health and Safety Executive (2002). EH40/2000 Occupation Exposure Limits 2002
(b) No chronic exposure guideline value in HKAQO
(c) No chronic exposure guideline value in WHO
(d) No chronic exposure guideline value in USEPA (IRIS)
(e) No chronic exposure guideline value in OEHHA
l WHO
l USEPA (IRIS database)
l Cal/EPA Acute RELs
l AEGL-1
l ERPG-1
l TEEL-1
l AEGL-2
Table 4.6 Exposure Limits/Reference Levels for COCs Acute Exposure
COC |
Exposure Limit/Reference Level (μg/m3, 1-hr averaging time) |
Source (a) |
Note |
Sb |
1,500/10 = 150 |
TEEL-1 |
c, e |
As |
30 /10 = 3 |
TEEL-1 |
c, e |
CO |
30,000 |
HKAQO |
|
Cd |
30/10 = 3 |
TEEL-1 |
c, e |
Cr (VI) |
30/10 = 3 |
TEEL-1 |
c, e |
Co |
3,000/10 = 300 |
TEEL-1 |
c, e |
Cu |
100 |
Cal/EPA Acute REL |
b |
Dioxins |
No guideline |
- |
d |
HCl |
2,100 |
Cal/EPA Acute REL |
b |
HF |
240 |
Cal/EPA Acute REL |
b |
Pb |
150/10 = 15 |
TEEL-1 |
c, e |
Mn |
3,000/10 = 300 |
TEEL-1 |
c, e |
Hg |
1.8 |
Cal/EPA Acute REL |
b |
NOx, as NO2 |
300 |
HKAQO |
|
Ni |
6.0 |
Cal/EPA Acute REL |
b |
Particulates |
No guideline |
- |
c |
SO2 |
800 |
HKAQO |
|
Tl |
300/10 = 30 |
TEEL-1 |
c, e |
V |
150/10 = 15 |
TEEL-1 |
c, e |
Notes:
(a) Sources of References:
HKAQO: http://www.epd-asg.gov.hk/english/backgd/hkaqo.php
WHO: http://www.euro.who.int/document/e71922.pdf
USEPA: http://cfpub.epa.gov/ncea/iris/index.cfm
Cal/EPA Acute REL http://www.oehha.ca.gov/air/acute_rels/allAcRELs.html
AEGL-1: http://www.epa/gov/opt/aegl/pubs/chemlist.htm
ERPG-1: http://www.aiha.org/1documents/Committees/ERP-erpglevels.pdf
TEEL-1: http://www.hss.energy.gov/HealthSafety/WSHP/chem_safety/teel.html
AEGL-2: http://www.epa/gov/opt/aegl/pubs/chemlist.htm
(b) No acute exposure guideline value in HKAQO, WHO and USEPA
(c) No acute exposure guideline value in HKAQO, WHO, USEPA, Cal/EPA Acute REL, AEGL-1, AEGL-2 and ERPG-1
(d) No acute exposure guideline value in all the above references sources.
(e) With reference to the Haber Rule, calculation of the 1-hour acute exposure limit/reference level from 15-minute acute exposure limit/reference level should be derived by (TEEL-1)/4. As a conservative approach, (TEEL-1)/10 has been adopted as the acute exposure limit/reference level.
l Cancer risk due to exposure to carcinogenic COCs;
l Non-carcinogenic health hazard due to long term exposure to COCs; and
l Non-carcinogenic health hazard due to acute exposure to COCs.
Cancer Riskinh(i) = [(Ci x EF x ED) x URFi] / (AT x 365 day/yr)............. Equation 4.1
where
Cancer Riskinh(i) = lifetime individual excess cancer risk through direct inhalation of carcinogenic COCi
Ci = air concentration of COCi at potential human receptor (μg/m3)
EF = exposure frequency (day/yr)
ED = exposure duration (yr)
AT = averaging time (yr)
URFi = Unit risk factor of COCi
Total Cancer Riskinh = Σ (Cancer Riskinh(i))............................................ Equation 4.2
where
Total Cancer Riskinh = lifetime individual excess cancer risk through direct inhalation of all carcinogenic COCs
Table 4.7 Risk Assessment Criteria for Cancer Risk
Acceptability of Cancer Risk |
Estimated Lifetime Individual Excess Cancer Risk |
Significant |
> 10-4 |
Risk should be reduced to “As Low As Reasonably Practicable” (ALARP) |
> 10-6 to 10-4 |
Insignificant |
£ 10-6 |
Near Field/ Far Field |
Air Sensitive Receiver (ASR) |
|||||||
Cd |
As |
Pb |
Cr (VI) |
Ni |
Dioxins |
|||
Near Field |
A1 |
9.86E-09 |
8.63E-08 |
6.90E-10 |
2.30E-06 |
2.19E-08 |
4.37E-10 |
2.42E-06 |
A2 |
6.41E-08 |
5.38E-07 |
4.31E-09 |
1.44E-05 |
1.36E-07 |
2.72E-09 |
1.51E-05 |
|
A3 |
6.41E-08 |
5.26E-07 |
4.21E-09 |
1.40E-05 |
1.33E-07 |
2.66E-09 |
1.48E-05 |
|
A4 |
3.45E-08 |
3.04E-07 |
2.43E-09 |
8.11E-06 |
7.70E-08 |
1.55E-09 |
8.53E-06 |
|
A5 |
5.42E-08 |
4.44E-07 |
3.55E-09 |
1.18E-05 |
1.12E-07 |
2.25E-09 |
1.25E-05 |
|
A6 |
2.96E-08 |
2.59E-07 |
2.07E-09 |
6.90E-06 |
6.56E-08 |
1.31E-09 |
7.26E-06 |
|
A7 |
0.00E+00 |
1.64E-08 |
1.32E-10 |
4.38E-07 |
4.16E-09 |
7.29E-11 |
4.59E-07 |
|
A8 |
4.44E-08 |
3.70E-07 |
2.96E-09 |
9.86E-06 |
9.37E-08 |
1.87E-09 |
1.04E-05 |
|
A9 |
1.48E-08 |
1.15E-07 |
9.21E-10 |
3.07E-06 |
2.92E-08 |
5.73E-10 |
3.23E-06 |
|
A22 |
2.47E-08 |
1.97E-07 |
1.58E-09 |
5.26E-06 |
5.00E-08 |
1.00E-09 |
5.53E-06 |
|
Far Field |
A10 |
5.71E-09 |
4.76E-08 |
3.81E-10 |
1.27E-06 |
1.21E-08 |
2.41E-10 |
1.34E-06 |
A11 |
1.11E-08 |
9.28E-08 |
7.43E-10 |
2.48E-06 |
2.35E-08 |
4.70E-10 |
2.60E-06 |
|
A12 |
7.27E-09 |
6.06E-08 |
4.85E-10 |
1.62E-06 |
1.53E-08 |
3.07E-10 |
1.70E-06 |
|
A13 |
6.04E-09 |
5.03E-08 |
4.03E-10 |
1.34E-06 |
1.27E-08 |
2.55E-10 |
1.41E-06 |
|
A14 |
4.03E-09 |
3.36E-08 |
2.69E-10 |
8.96E-07 |
8.51E-09 |
1.70E-10 |
9.42E-07 |
|
A15 |
4.56E-09 |
3.80E-08 |
3.04E-10 |
1.01E-06 |
9.63E-09 |
1.93E-10 |
1.07E-06 |
|
A16 |
5.44E-09 |
4.53E-08 |
3.63E-10 |
1.21E-06 |
1.15E-08 |
2.30E-10 |
1.27E-06 |
|
A17 |
6.04E-09 |
5.03E-08 |
4.03E-10 |
1.34E-06 |
1.27E-08 |
2.55E-10 |
1.41E-06 |
|
A18 |
6.45E-09 |
5.37E-08 |
4.30E-10 |
1.43E-06 |
1.36E-08 |
2.72E-10 |
1.51E-06 |
|
A19 |
7.51E-09 |
6.26E-08 |
5.01E-10 |
1.67E-06 |
1.59E-08 |
3.17E-10 |
1.76E-06 |
|
A20 |
6.12E-09 |
5.10E-08 |
4.08E-10 |
1.36E-06 |
1.29E-08 |
2.58E-10 |
1.43E-06 |
|
A21 |
9.63E-09 |
8.02E-08 |
6.42E-10 |
2.14E-06 |
2.03E-08 |
4.06E-10 |
2.25E-06 |
|
A23 |
6.29E-09 |
5.24E-08 |
4.19E-10 |
1.40E-06 |
1.33E-08 |
2.65E-10 |
1.47E-06 |
|
A24 |
3.73E-09 |
3.11E-08 |
2.49E-10 |
8.29E-07 |
7.87E-09 |
1.57E-10 |
8.72E-07 |
|
A25 |
3.90E-09 |
3.25E-08 |
2.60E-10 |
8.68E-07 |
8.24E-09 |
1.65E-10 |
9.13E-07 |
|
A26 |
4.04E-09 |
3.36E-08 |
2.69E-10 |
8.97E-07 |
8.52E-09 |
1.70E-10 |
9.44E-07 |
|
A27 |
4.25E-09 |
3.54E-08 |
2.84E-10 |
9.45E-07 |
8.98E-09 |
1.80E-10 |
9.94E-07 |
|
A28 |
4.14E-09 |
3.45E-08 |
2.76E-10 |
9.19E-07 |
8.73E-09 |
1.75E-10 |
9.67E-07 |
|
A29 |
4.53E-09 |
3.78E-08 |
3.02E-10 |
1.01E-06 |
9.57E-09 |
1.91E-10 |
1.06E-06 |
|
A30 |
4.91E-09 |
4.09E-08 |
3.27E-10 |
1.09E-06 |
1.04E-08 |
2.07E-10 |
1.15E-06 |
|
A31 |
5.14E-09 |
4.28E-08 |
3.43E-10 |
1.14E-06 |
1.09E-08 |
2.17E-10 |
1.20E-06 |
|
A32 |
4.37E-09 |
3.65E-08 |
2.92E-10 |
9.72E-07 |
9.23E-09 |
1.85E-10 |
1.02E-06 |
COC |
Sb |
As |
Cd |
Cr (VI) |
Co |
Cu |
Dioxins |
HCl |
HF |
Pb(1) |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
1 |
0.03 |
0.02 |
0.008 |
0.2 |
2 |
4E-05 |
20 |
14 |
1.5 |
0.15 |
1 |
0.05 |
1 |
0.1 |
Background Conc. (μg/m3) |
N/A |
0.0063 |
0.00173 |
0.00018 |
N/A |
0.168 |
6.5E-8 |
N/A |
N/A |
0.14 |
0.040 |
0.00020 |
0.0059 |
N/A |
0.0074 |
Non-carcinogenic Health Impact Significant? |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Note (1): Since the long term criteria for lead is based on the 3-month average HKAQO, a 3-month average background concentration of lead was thus conservatively estimated based on the annual average background concentration of lead with a general power law relationship in the form of C3-month = CAnnual x (12 month / 3 month)p, where C3-month is the 3-month average concentration; CAnnual is the annual average concentration; and p is the power law exponent conservatively taken as 0.5. In other words, C3-month = CAnnual x 2.
COC |
ASR |
Sb |
As |
Cd |
Cr (VI) |
Co |
Cu |
Dioxins |
HCl |
HF |
Pb(1) |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
- |
1 |
0.03 |
0.02 |
0.008 |
0.2 |
2 |
4E-05 |
20 |
14 |
1.5 |
0.15 |
1 |
0.05 |
1 |
0.1 |
Long Term Average Conc. (μg/m3) |
A1 |
2.30E-04 |
6.52E-03 |
1.86E-03 |
6.90E-04 |
2.10E-04 |
1.69E-01 |
6.52E-08 |
4.39E-02 |
6.80E-04 |
1.43E-01 |
4.04E-02 |
3.40E-04 |
6.36E-03 |
1.30E-04 |
7.91E-03 |
A2 |
1.34E-03 |
7.62E-03 |
1.97E-03 |
1.74E-03 |
1.31E-03 |
1.70E-01 |
6.54E-08 |
1.24E-01 |
2.92E-03 |
1.45E-01 |
4.15E-02 |
4.40E-04 |
7.43E-03 |
2.40E-04 |
8.96E-03 |
|
A3 |
1.31E-03 |
7.59E-03 |
1.97E-03 |
1.71E-03 |
1.28E-03 |
1.70E-01 |
6.54E-08 |
1.49E-01 |
2.93E-03 |
1.45E-01 |
4.14E-02 |
4.40E-04 |
7.42E-03 |
2.40E-04 |
8.93E-03 |
|
A4 |
7.80E-04 |
7.06E-03 |
1.91E-03 |
1.18E-03 |
7.40E-04 |
1.69E-01 |
6.53E-08 |
1.02E-01 |
1.92E-03 |
1.44E-01 |
4.09E-02 |
3.80E-04 |
6.90E-03 |
1.80E-04 |
8.40E-03 |
|
A5 |
1.12E-03 |
7.39E-03 |
1.99E-03 |
1.61E-03 |
1.08E-03 |
1.70E-01 |
6.54E-08 |
1.34E-01 |
2.56E-03 |
1.46E-01 |
4.14E-02 |
4.60E-04 |
7.30E-03 |
2.60E-04 |
8.83E-03 |
|
A6 |
6.90E-04 |
6.95E-03 |
1.95E-03 |
1.15E-03 |
6.30E-04 |
1.69E-01 |
6.54E-08 |
1.71E-01 |
1.94E-03 |
1.45E-01 |
4.10E-02 |
4.20E-04 |
6.89E-03 |
2.20E-04 |
8.37E-03 |
|
A7 |
8.00E-05 |
6.36E-03 |
1.86E-03 |
5.40E-04 |
4.00E-05 |
1.68E-01 |
6.52E-08 |
1.46E-01 |
4.90E-04 |
1.43E-01 |
4.02E-02 |
3.30E-04 |
6.24E-03 |
1.30E-04 |
7.76E-03 |
|
A8 |
1.06E-03 |
7.26E-03 |
2.00E-03 |
1.43E-03 |
9.00E-04 |
1.70E-01 |
6.59E-08 |
1.12E-01 |
3.51E-03 |
1.48E-01 |
4.13E-02 |
4.70E-04 |
7.36E-03 |
2.70E-04 |
8.65E-03 |
|
A9 |
3.10E-04 |
6.59E-03 |
1.87E-03 |
7.20E-04 |
2.80E-04 |
1.69E-01 |
6.52E-08 |
6.79E-02 |
8.80E-04 |
1.43E-01 |
4.05E-02 |
3.40E-04 |
6.42E-03 |
1.40E-04 |
7.94E-03 |
|
A22 |
5.50E-04 |
6.81E-03 |
1.90E-03 |
9.61E-04 |
4.80E-04 |
1.69E-01 |
6.54E-08 |
1.84E-01 |
1.76E-03 |
1.45E-01 |
4.07E-02 |
3.80E-04 |
6.73E-03 |
1.70E-04 |
8.18E-03 |
|
Non-carcinogenic Health Impact Significant? |
- |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Note (1): Since the long term criteria for lead is based on the 3-month average HKAQO, the long term average concentration of lead in 3-month averages was thus conservatively estimated based on the predicted annual average concentration of lead with a general power law relationship in the form of C3-month = CAnnual x (12 month / 3 month)p, where C3-month is the 3-month average concentration; CAnnual is the annual average concentration; and p is the power law exponent conservatively taken as 0.5. In other words, C3-month = CAnnual x 2.
COC |
ASR |
Sb |
As |
Cd |
Cr (VI) |
Co |
Cu |
Dioxins |
HCl |
HF |
Pb(1) |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
- |
1 |
0.03 |
0.02 |
0.008 |
0.2 |
2 |
4E-05 |
20 |
14 |
1.5 |
0.15 |
1 |
0.05 |
1 |
0.1 |
Long Term Average Conc. (μg/m3)
|
A10 |
1.26E-04 |
6.43E-03 |
1.85E-03 |
5.76E-04 |
1.16E-04 |
1.68E-01 |
6.51E-08 |
3.24E-02 |
3.82E-04 |
1.43E-01 |
4.04E-02 |
3.22E-04 |
6.25E-03 |
1.22E-04 |
7.80E-03 |
A11 |
4.16E-04 |
6.60E-03 |
1.93E-03 |
7.58E-04 |
2.26E-04 |
1.69E-01 |
6.59E-08 |
1.52E-01 |
2.51E-03 |
1.47E-01 |
4.05E-02 |
4.03E-04 |
6.75E-03 |
2.03E-04 |
7.98E-03 |
|
A12 |
1.83E-04 |
6.46E-03 |
1.95E-03 |
8.58E-04 |
1.47E-04 |
1.69E-01 |
6.53E-08 |
7.81E-02 |
7.79E-04 |
1.45E-01 |
4.05E-02 |
4.25E-04 |
6.48E-03 |
2.25E-04 |
8.08E-03 |
|
A13 |
2.82E-04 |
6.48E-03 |
3.37E-03 |
4.43E-03 |
1.22E-04 |
1.73E-01 |
6.58E-08 |
8.89E-02 |
1.96E-03 |
1.74E-01 |
4.30E-02 |
1.84E-03 |
9.20E-03 |
1.64E-03 |
1.17E-02 |
|
A14 |
3.71E-04 |
6.49E-03 |
2.32E-03 |
1.68E-03 |
8.17E-05 |
1.71E-01 |
6.64E-08 |
5.60E-02 |
3.28E-03 |
1.56E-01 |
4.08E-02 |
7.98E-04 |
7.52E-03 |
5.88E-04 |
8.90E-03 |
|
A15 |
3.63E-04 |
6.50E-03 |
2.21E-03 |
1.39E-03 |
9.25E-05 |
1.70E-01 |
6.63E-08 |
4.61E-02 |
3.14E-03 |
1.54E-01 |
4.07E-02 |
6.89E-04 |
7.30E-03 |
4.79E-04 |
8.61E-03 |
|
A16 |
6.40E-04 |
6.62E-03 |
3.03E-03 |
3.18E-03 |
1.10E-04 |
1.73E-01 |
6.75E-08 |
9.61E-02 |
6.01E-03 |
1.73E-01 |
4.30E-02 |
1.52E-03 |
9.10E-03 |
1.30E-03 |
1.04E-02 |
|
A17 |
3.19E-03 |
7.62E-03 |
2.78E-03 |
1.27E-03 |
1.22E-04 |
1.81E-01 |
7.95E-08 |
3.34E-01 |
3.35E-02 |
2.06E-01 |
4.17E-02 |
1.32E-03 |
1.28E-02 |
1.05E-03 |
8.46E-03 |
|
A18 |
5.91E-04 |
6.61E-03 |
1.84E-03 |
3.25E-04 |
1.31E-04 |
1.70E-01 |
6.72E-08 |
9.25E-02 |
5.24E-03 |
1.49E-01 |
4.02E-02 |
3.23E-04 |
6.95E-03 |
1.13E-04 |
7.54E-03 |
|
A19 |
5.12E-04 |
6.59E-03 |
1.84E-03 |
3.66E-04 |
1.52E-04 |
1.70E-01 |
6.67E-08 |
9.96E-02 |
4.20E-03 |
1.47E-01 |
4.03E-02 |
3.15E-04 |
6.78E-03 |
1.05E-04 |
7.58E-03 |
|
A20 |
7.14E-04 |
6.65E-03 |
1.90E-03 |
3.59E-04 |
1.24E-04 |
1.70E-01 |
6.78E-08 |
1.15E-01 |
6.67E-03 |
1.52E-01 |
4.04E-02 |
3.82E-04 |
7.23E-03 |
1.72E-04 |
7.57E-03 |
|
A21 |
4.25E-04 |
6.59E-03 |
1.89E-03 |
6.27E-04 |
1.95E-04 |
1.69E-01 |
6.61E-08 |
1.27E-01 |
2.85E-03 |
1.47E-01 |
4.05E-02 |
3.70E-04 |
6.73E-03 |
1.60E-04 |
7.85E-03 |
|
A23 |
8.67E-04 |
6.72E-03 |
1.91E-03 |
3.44E-04 |
1.27E-04 |
1.71E-01 |
6.85E-08 |
1.38E-01 |
8.23E-03 |
1.55E-01 |
4.04E-02 |
4.03E-04 |
7.52E-03 |
1.83E-04 |
7.56E-03 |
|
A24 |
2.23E-04 |
6.43E-03 |
2.26E-03 |
1.55E-03 |
7.56E-05 |
1.70E-01 |
6.57E-08 |
7.46E-02 |
1.81E-03 |
1.52E-01 |
4.09E-02 |
7.28E-04 |
7.07E-03 |
5.28E-04 |
8.77E-03 |
|
A25 |
1.65E-04 |
6.41E-03 |
2.50E-03 |
2.21E-03 |
7.92E-05 |
1.70E-01 |
6.54E-08 |
2.20E-02 |
1.15E-03 |
1.56E-01 |
4.14E-02 |
9.68E-04 |
7.46E-03 |
7.68E-04 |
9.43E-03 |
|
A26 |
2.18E-04 |
6.44E-03 |
2.47E-03 |
2.19E-03 |
8.19E-05 |
1.70E-01 |
6.57E-08 |
7.50E-02 |
1.70E-03 |
1.56E-01 |
4.10E-02 |
9.38E-04 |
7.48E-03 |
7.38E-04 |
9.41E-03 |
|
A27 |
2.21E-04 |
6.43E-03 |
2.13E-03 |
1.28E-03 |
8.63E-05 |
1.69E-01 |
6.57E-08 |
5.36E-02 |
1.67E-03 |
1.49E-01 |
4.05E-02 |
5.99E-04 |
6.84E-03 |
3.99E-04 |
8.50E-03 |
|
A28 |
1.54E-04 |
6.41E-03 |
1.99E-03 |
8.74E-04 |
8.39E-05 |
1.69E-01 |
6.53E-08 |
2.60E-02 |
8.78E-04 |
1.46E-01 |
4.05E-02 |
4.58E-04 |
6.54E-03 |
2.58E-04 |
8.09E-03 |
|
A29 |
1.66E-04 |
6.42E-03 |
2.53E-03 |
2.24E-03 |
9.19E-05 |
1.70E-01 |
6.54E-08 |
3.36E-02 |
1.01E-03 |
1.56E-01 |
4.16E-02 |
9.99E-04 |
7.46E-03 |
7.99E-04 |
9.46E-03 |
|
A30 |
2.53E-04 |
6.45E-03 |
2.12E-03 |
1.30E-03 |
9.95E-05 |
1.69E-01 |
6.58E-08 |
4.97E-02 |
1.91E-03 |
1.49E-01 |
4.04E-02 |
5.90E-04 |
6.84E-03 |
3.90E-04 |
8.52E-03 |
|
A31 |
2.16E-04 |
6.45E-03 |
1.97E-03 |
8.85E-04 |
1.04E-04 |
1.69E-01 |
6.56E-08 |
7.53E-02 |
1.46E-03 |
1.46E-01 |
4.04E-02 |
4.40E-04 |
6.55E-03 |
2.40E-04 |
8.10E-03 |
|
A32 |
3.26E-04 |
6.48E-03 |
2.42E-03 |
1.84E-03 |
8.87E-05 |
1.70E-01 |
6.61E-08 |
3.36E-02 |
2.77E-03 |
1.56E-01 |
4.16E-02 |
8.89E-04 |
7.48E-03 |
6.89E-04 |
9.06E-03 |
|
Non- carcinogenic Health Impact Significant? |
- |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Note (1): Since the long term criteria for lead is based on the 3-month average HKAQO, the long term average concentration of lead in 3-month averages was thus conservatively estimated based on the predicted annual average concentration of lead with a general power law relationship in the form of C3-month = CAnnual x (12 month / 3 month)p, where C3-month is the 3-month average concentration; CAnnual is the annual average concentration; and p is the power law exponent conservatively taken as 0.5. In other words, C3-month = CAnnual x 2.
COC |
Sb |
As |
CO |
Cd |
Cr (VI) |
Co |
Cu |
HCl |
HF |
Pb |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
150 |
3 |
30000 |
3 |
3 |
300 |
100 |
2100 |
240 |
15 |
300 |
1.8 |
6 |
30 |
15 |
Background Conc. (μg/m3) |
N/A |
0.0063 |
932 |
0.00173 |
0.00018 |
N/A |
0.168 |
N/A |
N/A |
0.070 |
0.040 |
0.00020 |
0.0059 |
N/A |
0.0074 |
Non-carcinogenic Health Impact Significant? |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
COC |
ASR |
Sb |
As |
CO |
Cd |
Cr (VI) |
Co |
Cu |
HCl |
HF |
Pb |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
- |
150 |
3 |
30000 |
3 |
3 |
300 |
100 |
2100 |
240 |
15 |
300 |
1.8 |
6 |
30 |
15 |
Hourly Average Conc. (μg/m3) |
A1 |
3.08E-02 |
3.71E-02 |
9.86E+02 |
4.80E-03 |
3.66E-02 |
3.08E-02 |
2.06E-01 |
4.77E+00 |
2.46E-01 |
2.06E-01 |
7.08E-02 |
3.27E-03 |
3.67E-02 |
3.07E-03 |
4.38E-02 |
A2 |
6.37E-02 |
7.00E-02 |
9.61E+02 |
8.10E-03 |
6.39E-02 |
6.37E-02 |
2.32E-01 |
8.66E+00 |
5.10E-01 |
1.34E-01 |
1.04E-01 |
6.57E-03 |
6.96E-02 |
6.37E-03 |
7.11E-02 |
|
A3 |
5.57E-02 |
6.20E-02 |
9.62E+02 |
7.30E-03 |
5.59E-02 |
5.57E-02 |
2.24E-01 |
8.84E+00 |
4.46E-01 |
1.26E-01 |
9.57E-02 |
5.77E-03 |
6.16E-02 |
5.57E-03 |
6.31E-02 |
|
A4 |
9.60E-02 |
1.02E-01 |
9.63E+02 |
1.13E-02 |
9.62E-02 |
9.60E-02 |
2.64E-01 |
1.20E+01 |
7.68E-01 |
1.66E-01 |
1.36E-01 |
9.80E-03 |
1.02E-01 |
9.60E-03 |
1.03E-01 |
|
A5 |
6.33E-02 |
6.96E-02 |
9.58E+02 |
8.06E-03 |
6.35E-02 |
6.33E-02 |
2.31E-01 |
8.48E+00 |
5.07E-01 |
1.33E-01 |
1.03E-01 |
6.53E-03 |
6.92E-02 |
6.33E-03 |
7.07E-02 |
|
A6 |
6.96E-02 |
7.59E-02 |
9.56E+02 |
8.69E-03 |
6.98E-02 |
6.96E-02 |
2.38E-01 |
8.70E+00 |
5.57E-01 |
1.40E-01 |
1.10E-01 |
7.16E-03 |
7.55E-02 |
6.96E-03 |
7.70E-02 |
|
A7 |
2.18E-02 |
2.81E-02 |
9.91E+02 |
3.91E-03 |
2.20E-02 |
2.18E-02 |
1.90E-01 |
1.37E+01 |
1.74E-01 |
9.18E-02 |
6.18E-02 |
2.38E-03 |
2.77E-02 |
2.18E-03 |
2.92E-02 |
|
A8 |
6.31E-02 |
6.94E-02 |
9.53E+02 |
8.04E-03 |
6.33E-02 |
6.31E-02 |
2.31E-01 |
7.82E+00 |
5.05E-01 |
1.33E-01 |
1.03E-01 |
6.51E-03 |
6.90E-02 |
6.31E-03 |
7.05E-02 |
|
A9 |
3.49E-02 |
4.12E-02 |
1.01E+03 |
1.14E-02 |
3.51E-02 |
3.49E-02 |
2.03E-01 |
9.11E+00 |
2.80E-01 |
1.70E-01 |
7.49E-02 |
9.89E-03 |
4.08E-02 |
9.68E-03 |
4.23E-02 |
|
A22 |
7.99E-02 |
8.62E-02 |
9.60E+02 |
9.72E-03 |
8.01E-02 |
7.99E-02 |
2.48E-01 |
1.22E+01 |
6.39E-01 |
1.50E-01 |
1.20E-01 |
8.19E-03 |
8.58E-02 |
7.99E-03 |
8.73E-02 |
|
Non- Carcinogenic Health Impact Significant? |
- |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
COC |
ASR |
Sb |
As |
CO |
Cd |
Cr |
Co |
Cu |
HCl |
HF |
Pb |
Mn |
Hg |
Ni |
Tl |
V |
Criteria Adopted / Derived (μg/m3) |
- |
150 |
3 |
30000 |
3 |
3 |
300 |
100 |
2100 |
240 |
15 |
300 |
1.8 |
6 |
30 |
15 |
Hourly Average Conc. (μg/m3) |
A10 |
5.99E-02 |
6.62E-02 |
1.14E+03 |
1.38E-02 |
6.01E-02 |
5.99E-02 |
2.28E-01 |
7.19E+00 |
4.79E-01 |
2.03E-01 |
9.99E-02 |
1.23E-02 |
6.58E-02 |
1.20E-02 |
6.73E-02 |
A11 |
5.13E-02 |
5.18E-02 |
1.12E+03 |
4.74E-02 |
1.29E-01 |
4.55E-02 |
3.72E-01 |
7.16E+00 |
5.55E-01 |
5.56E-01 |
8.55E-02 |
4.59E-02 |
1.07E-01 |
4.57E-02 |
1.36E-01 |
|
A12 |
3.37E-02 |
4.00E-02 |
1.19E+03 |
1.78E-02 |
4.91E-02 |
3.37E-02 |
2.30E-01 |
4.49E+01 |
2.70E-01 |
2.33E-01 |
8.21E-02 |
1.63E-02 |
4.13E-02 |
1.61E-02 |
5.63E-02 |
|
A13 |
9.55E-02 |
1.02E-01 |
2.81E+03 |
1.18E-01 |
2.58E-01 |
9.55E-02 |
5.83E-01 |
2.80E+01 |
7.64E-01 |
1.53E+00 |
3.46E-01 |
1.18E-01 |
2.84E-01 |
1.16E-01 |
2.66E-01 |
|
A14 |
1.20E-01 |
5.30E-02 |
1.31E+03 |
3.38E-02 |
9.39E-02 |
1.24E-02 |
6.44E-01 |
1.82E+01 |
1.30E+00 |
1.21E+00 |
1.07E-01 |
3.23E-02 |
2.42E-01 |
3.21E-02 |
1.01E-01 |
|
A15 |
2.34E-02 |
2.28E-02 |
1.17E+03 |
2.41E-02 |
6.32E-02 |
1.65E-02 |
2.58E-01 |
7.75E+00 |
2.48E-01 |
3.37E-01 |
7.83E-02 |
2.26E-02 |
5.98E-02 |
2.24E-02 |
7.04E-02 |
|
A16 |
8.98E-02 |
4.14E-02 |
1.90E+03 |
4.53E-02 |
1.23E-01 |
3.33E-02 |
5.40E-01 |
1.73E+01 |
9.72E-01 |
1.08E+00 |
1.98E-01 |
4.39E-02 |
2.08E-01 |
4.36E-02 |
1.30E-01 |
|
A17 |
3.00E-01 |
1.24E-01 |
1.45E+03 |
6.03E-02 |
1.08E-01 |
6.69E-02 |
1.36E+00 |
2.60E+01 |
3.25E+00 |
2.92E+00 |
1.24E-01 |
6.56E-02 |
5.99E-01 |
5.86E-02 |
1.15E-01 |
|
A18 |
6.35E-02 |
3.12E-02 |
9.51E+02 |
1.41E-02 |
2.19E-02 |
2.17E-02 |
4.20E-01 |
5.51E+00 |
6.87E-01 |
6.71E-01 |
6.17E-02 |
1.42E-02 |
1.31E-01 |
1.24E-02 |
2.91E-02 |
|
A19 |
3.97E-02 |
3.29E-02 |
1.14E+03 |
3.06E-02 |
7.96E-02 |
2.66E-02 |
3.24E-01 |
3.57E+00 |
4.29E-01 |
4.42E-01 |
7.60E-02 |
2.91E-02 |
8.38E-02 |
2.88E-02 |
8.68E-02 |
|
A20 |
5.70E-02 |
3.30E-02 |
1.14E+03 |
1.29E-02 |
2.69E-02 |
2.67E-02 |
3.95E-01 |
6.09E+00 |
6.17E-01 |
6.11E-01 |
7.35E-02 |
1.26E-02 |
1.19E-01 |
1.11E-02 |
3.41E-02 |
|
A21 |
4.28E-02 |
4.91E-02 |
1.17E+03 |
5.99E-02 |
1.65E-01 |
4.28E-02 |
3.35E-01 |
6.19E+00 |
3.42E-01 |
6.69E-01 |
8.28E-02 |
5.84E-02 |
1.20E-01 |
5.82E-02 |
1.72E-01 |
|
A23 |
7.22E-02 |
3.46E-02 |
1.13E+03 |
1.58E-02 |
2.31E-02 |
2.29E-02 |
4.54E-01 |
7.14E+00 |
7.81E-01 |
7.53E-01 |
7.47E-02 |
1.60E-02 |
1.48E-01 |
1.41E-02 |
3.03E-02 |
|
A24 |
5.56E-02 |
2.80E-02 |
1.94E+03 |
2.76E-02 |
6.50E-02 |
2.15E-02 |
3.89E-01 |
4.36E+01 |
6.02E-01 |
6.55E-01 |
2.03E-01 |
2.65E-02 |
1.24E-01 |
2.58E-02 |
7.22E-02 |
|
A25 |
1.71E-02 |
2.34E-02 |
3.16E+03 |
1.01E-01 |
2.21E-01 |
1.71E-02 |
3.50E-01 |
3.65E+00 |
1.37E-01 |
9.69E-01 |
4.03E-01 |
9.97E-02 |
1.66E-01 |
9.95E-02 |
2.28E-01 |
|
A26 |
2.50E-02 |
3.13E-02 |
1.98E+03 |
7.50E-02 |
1.84E-01 |
2.50E-02 |
3.33E-01 |
4.38E+01 |
2.37E-01 |
7.67E-01 |
2.10E-01 |
7.35E-02 |
1.34E-01 |
7.33E-02 |
1.91E-01 |
|
A27 |
2.58E-02 |
2.44E-02 |
1.13E+03 |
2.15E-02 |
5.73E-02 |
1.81E-02 |
2.56E-01 |
1.45E+01 |
2.64E-01 |
2.87E-01 |
7.45E-02 |
2.00E-02 |
5.42E-02 |
1.98E-02 |
6.45E-02 |
|
A28 |
2.43E-02 |
2.32E-02 |
1.16E+03 |
2.36E-02 |
6.16E-02 |
1.69E-02 |
2.54E-01 |
6.87E+00 |
2.53E-01 |
2.99E-01 |
7.74E-02 |
2.21E-02 |
5.08E-02 |
2.19E-02 |
6.88E-02 |
|
A29 |
3.00E-02 |
2.72E-02 |
2.84E+03 |
1.03E-01 |
2.40E-01 |
2.09E-02 |
3.71E-01 |
1.14E+01 |
3.15E-01 |
9.93E-01 |
3.64E-01 |
1.01E-01 |
1.82E-01 |
1.01E-01 |
2.47E-01 |
|
A30 |
1.06E-01 |
4.76E-02 |
1.10E+03 |
3.29E-02 |
8.75E-02 |
2.26E-02 |
5.88E-01 |
1.04E+01 |
1.15E+00 |
1.07E+00 |
6.85E-02 |
3.13E-02 |
2.15E-01 |
3.11E-02 |
9.48E-02 |
|
A31 |
6.94E-02 |
4.73E-02 |
1.14E+03 |
1.64E-02 |
4.14E-02 |
4.10E-02 |
4.44E-01 |
4.48E+01 |
7.51E-01 |
7.31E-01 |
8.10E-02 |
1.58E-02 |
1.43E-01 |
1.47E-02 |
4.86E-02 |
|
A32 |
2.28E-02 |
2.59E-02 |
3.10E+03 |
4.75E-02 |
9.17E-02 |
1.96E-02 |
2.68E-01 |
4.68E+00 |
2.47E-01 |
4.14E-01 |
3.93E-01 |
4.60E-02 |
7.53E-02 |
4.58E-02 |
9.89E-02 |
|
Non- carcinogenic Health Impact Significant? |
- |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
l Release of COCs into the environment;
l Transport of the COCs by air dispersion, in a variety of different and variable environments;
l Potential for adverse health effects in human, as extrapolated from animal studies; and
l Probability of adverse effects in a human population that is highly variable genetically, and in age, activity level and lifestyle.
l A high degree of uncertainty would be encountered when the health risk is to be quantified, due to lack of precise and comprehensive data;
l The degree of survival and transport of pathogens in the environment is limited; and
l Qualitative risk assessment is well recognized as appropriate methodology for microbial risk assessment and has been adopted for both local and overseas studies.
l Identification of the hazards associated with microbes during transportation, storage and handling of dewatered sewage sludge
l An assessment of the likelihood and consequences of exposure of microbes during transportation, storage and handling of dewatered sewage sludge
l A qualitative assessment of the likely level of risks associated with the identified hazards
l Identification and recommendation of means by which the potential risks could be further reduced
l Sludge collection
l Sludge transport
l Sludge reception and handling (at STF)
l Temporary storage of sludge (at STF)
l Sludge conveyance from temporary storage to incinerator unit (at STF)
l Sludge incineration (at STF)
l Wash down facilities (at STF)
l Maintenance and repair activities (at STF)
Table 4.15 Property Words and Guidewords used in HAZOP Workshop
Property Word |
Guideword |
Amount |
More / less / other / incorrect |
Driver / operator |
Error |
Equipment |
Down / failure / accident |
Sealing |
No, inadequate, inappropriate |
Stowage / Storage |
Incorrect / inadequate / inappropriate /error |
Temperature |
High / low |
Timing / time |
More / less / no / before / after |
Drainage |
No / blocked |
l 1 – low likelihood
l 2 – medium likelihood
l 3 – high likelihood
l 1 – unlikely to cause human disease
l 2 – can cause human disease and may be a hazard to employees; it is unlikely to spread to the community and there is usually effective prophylaxis or treatment available
l 3 – can cause severe human disease and may be a serious hazard to employees; it may spread to the community but there is usually effective prophylaxis or treatment available
l 4 – causes severe human disease and is a serious hazard to employees; it is likely to spread to the community and there is usually no effective prophylaxis or treatment available
|
|
Hazard Consequence |
|||
|
|
1 |
2 |
3 |
4 |
Hazard Likelihood |
1 – Low |
Low |
Low |
Medium |
Medium |
2 – Medium |
Low |
Medium |
Medium |
High |
|
3 – High |
Medium |
Medium |
High |
High |
l “Low” risk level – the risk of the hazard could be considered to be broadly acceptable. In such cases, no further mitigation measures are considered necessary
l “Medium” risk level – the risk of the hazard could be considered to be tolerable, mitigation measures and/or safeguard measures can be provided to reduce the risk level to “As Low As Reasonably Practicable”
l “High” risk level – the risk of the hazard could be considered to be unacceptable. Mitigation measures should be applied to reduce the risk level
Table 4.17 Summary of Risk Assessment Results
Sludge Conveyance from Temporary Storage Tank to Incinerator |
|||
l Apply good practice during unloading of dewatered sewage sludge to skip / container of transport vehicle
l The dewatered sewage sludge unloading process should be supervised by workers on-site and drivers
l The workers handling the dewatered sewage sludge spillage during transport in case of accident should wear personal protective equipment
l Provide signage to assist driver to stop at appropriate unloading position
l Provide sufficient training to drivers for the dewatered sewage sludge transporting vehicles
l The on-site workers responsible for cleaning should wear personal protective equipment
l Vehicle cleaning system should be provided to clean the dewatered sewage sludge transporting vehicle before they leave the STF
l Monitor and control the traffic flow inside the reception hall of the STF
l Provide signage for clear indication of vehicle travelling route
l In case manual handling of dewatered sewage sludge is needed, the workers involved should wear personal protective equipment
l Detection device / alarm should be installed to prevent overfilling of temporary sludge storage tank
l Monitor and control the dewatered sewage sludge unloading process
l The on-site workers responsible for cleaning should wear personal protective equipment
l A safety margin should be considered for the design capacity of STF
l Emergency plan should be established and implemented to handle the situation of incineration units being down
l Monitoring and control system should be installed to monitor and control the performance of incineration process
l In case handling of incomplete combusted dewatered sewage sludge is needed, the workers involved should wear personal protective equipment
l The on-site workers responsible for cleaning should wear personal protective equipment
l Frequent and sufficient maintenance should be provided for the drainage system of STF
l Multiple outlets in drainage system should be designed and provided to reduce the likelihood of drainage blockage
l Maintenance workers should wear personal protective equipment
l Health risks for radon emission due to construction and operation activities of the STF would be insignificant;
l Radiation exposure to the staff in the STF from the radon flux out of the ground filled by PFA may be increased but would not be of great significance with implementation of proper mitigation measures; and
l A review of radon risk should be undertaken, based on the confirmed construction method.
l Exposures from building materials; and
l Exposures from disposal sites under outdoors and indoors conditions.
Table 4.18 Radium Equivalent Activities of PFA, FBA and Coal from the Castle Peak Power Station
Coal Source |
Date of Sample Collection |
Radium equivalent activity (Bq/kg) |
||
Coal |
PFA |
FBA |
||
Columbia |
22/02/89 |
|
233 |
255 |
Australia |
22/02/89 |
|
373 |
347 |
Australia |
02/03/89 |
|
532 |
163 |
South Africa |
07/03/89 |
|
407 |
343 |
South Africa |
08/03/89 |
|
|
|
South Africa |
10/03/89 |
72 |
423 |
382 |
South Africa |
15/03/89 |
66 |
443 |
335 |
Australia |
19/03/89 |
27 |
211 |
197 |
Sampled by RO |
1987 |
|
377a |
|
Source not specified |
1987 |
|
378a |
|
Remark: a Data from RO
Table 4.19 Summary of Estimates of Annual Effective Dose Equivalents
Situation |
Normal Ground |
PFA disposal site 50cm soil cover |
PFA disposal site no soil cover |
||||||
From g |
From Rn |
Total |
From g |
From Rn |
Total |
From g |
From Rn |
Total |
|
Indoors |
|||||||||
All-brick dwelling |
0.740 |
0.260 |
1.000 |
0.750 |
0.360 |
1.110 |
0.760 |
0.780 |
1.540 |
Heavy block dwelling |
0.700 |
0.290 |
0.990 |
0.710 |
0.400 |
1.110 |
0.720 |
0.820 |
1.540 |
Light block dwelling |
0.530 |
0.340 |
0.870 |
0.540 |
0.440 |
0.980 |
0.560 |
0.860 |
1.420 |
Workers such as farm or disposal site labour (2000 hrs in a year) |
0.056 |
0.057 |
0.113 |
0.070 |
0.060 |
0.130 |
0.130 |
0.060 |
0.190 |
Members of the public (500 hrs in a year) |
0.014 |
0.007 |
0.021 |
0.018 |
0.008 |
0.026 |
N/A |
N/A |
N/A |
(8,760 hrs in a year) |
|
|
0.011 |
|
|
- |
|
|
0.035 |
Note: Estimated Values (including values from gamma ray dose and radon) were rounded to two significant figures
N/A: Not applicable
All units in mSv
AIHA (2005). Current AIHA ERPGs (2005). Available online: www.aiha.org/committees/documents/erpglevels.pdf.
California EPA (1999). Air Toxics Hot Spots Program Risk Assessment Guidelines. Part 1 – The Determination of Acute Reference Exposure Levels for Airborne Toxicants.
DoE. Revision 21 of AEGLs, ERPGs and TEELs for Chemicals of Concern. Available online: http://tis-hq.eh.doe.gov/web/chem_safety/teel.html.
EPD (2001). A Guidance Note on the Best Practicable Means for Incinerators (Municipal Waste Incineration). BPM12/1.
ERM (2001). Preliminary Project Feasibility Study for Sludge Treatment Facilities: Preliminary Environmental Review.
ERM (2003). Feasibility Study of Animal Carcass Treatment Facilities: EIA Report (Agreement No. CE 68/2002).
HSE (2002). EH40/2002 Occupational Exposure Limits 2002.
HSE (2004). The Approved List of Biological Agents.
MWH (2003). Additional Study of Waste-to-Energy Facilities (WEF) – EIA Report (Agreement No. CE 23/2002).
NIOSH (2002). Guidance for Controlling Potential Risks to Workers Exposed to Class B Biosolids.
OEHHA (2005a). All Chronic Reference Exposure Levels Adopted by OEHHA. Available online: www.oehha.ca.gov/air/chronic_rels/AllChrels.html
OEHHA (2005b). Toxicity Criteria Database. Available online: www.oehha.ca.gov/risk/chemicalDB/index.asp.
USEPA. Acute Exposure Guideline Levels (AEGLs). Available online: www.epa.gov/oppt/aegl/chemlist.htm.
USEPA (2005). Human Health Risk Assessment Protocol for Hazardous Waste Combustion Facilities – Final.
USEPA. Integrated Risk Information System (IRIS) Database. Available online: www.epa.gov/iris.
WHO (2000). Air Quality Guidelines for Europe, 2nd edition.
Green, B.M.R. (1986). Radiological Significance of the Utilization and Disposal of Coal Fly Ash from Power Stations Report for Central Electricity Generating Board. National Radiological Protection Board, UK.
Yu, K.N., Young, E.C.M. and Stokes, M.J (1988). The Radon-induced Lung Cancer Mortality in Hong Kong Deduced from a Relative Risk Model.
EPD (1999) ProPECC Note PN 1/99 Control of Radon Concentration in New Buildings
Binnie Consultants Limited (1990). The Environmental Aspects of Fuel Ash Utilization.
CDM (2001), Feasibility Study of Waste-to-Energy Facilities – EIA (Ha Pak Nai) (Agreement No. CE97/96)
International Commission on Radiological Protection (IRCP) (2007), IRCP Recommendation (Publication 103)
[1] ERM (2001); ERM (2003); MWH (2003).
[2] Lifetime individual excess cancer risk denotes the incremental lifetime cancer risk imposed to the impacted receptors due to the stack emissions from the STF operation.
[3] 0.05mg/m3 as the limit for total concentration of Cd and Tl; 0.5mg/m3 as the limit for total concentration of Sb, As, Pb, Co, Cr, Mn, V and Ni.
[4] Unit risk factors, air quality standards/occupational exposure limit value for long term COC exposure as well as exposure limits and reference level for acute COC exposure.